drugset / Trial / NCT01438801
Predictive Value of the Insulin-like Growth Factor-1 (IGF-1) Generation Test for the Growth Response to Growth Hormone Treatment (PRED-IGF)
NaSingle-groupOpen-labelDiagnostic
Summary
The evaluation of a standardized diagnostic test to predict the growth response in a 1 year trial with Growth Hormone (GH) treatment (carried out in the context of regular patient care) in non GH deficient short children with low serum insulin-like growth factor-1 (IGF-1).
Timeline
- Start
- 2013-05
- Primary completion
- 2013-05-31
- Completion
- 2013-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Somatropin | Protein / enzyme biologic | 0.7 mg/m2 | Subcutaneous |
| Subject | Somatropin | Protein / enzyme biologic | 1.4 mg/m2 | Subcutaneous |
| Subject | Somatropin | Protein / enzyme biologic | 2.8 mg/m2 | Subcutaneous |